LIFE SCIENCES
ACCELERATOR INCUBATOR

WE TURN RESEARCH INTO ENTERPRISE

8

months of acceleration

50+

mentors involved

1.610.000€

of investments

13

teams selected

G-FACTOR

G-Factor is a reactive environment whose aim is to support new entrepreneurs and researchers with high entrepreneurial potential to become companies able to successfully establish themselves in the market, creating replicable and scalable models. Three years after its establishment, G-Factor has consolidated its position as an accelerator for start-ups in the life sciences sector, while opening up to other vertical sectors.

We invest in innovative start-ups and teams by providing capital and expertise because we believe that the mix of finance and training is crucial to entrepreneurial success.

LEGGI TUTTOMOSTRA MENO

I-Tech Innovation Programme 2021 FAQ

I-Tech Innovation 2021 is the new programme promoted by Fondazione Golinelli and CRIF. In the previous two editions, 15 start-ups in the Life Sciences sector were funded and accelerated, selected from over 250 applications with an investment of €1,625,000. Thanks to the partnership between the Fondazione and CRIF, G-Factor is now inaugurating two new verticals: FinTech & InsureTech and AgriTech & FoodTech, in addition to Life Sciences & Digital Health.

The 2021 Call, with an investment budget of €1,610,000, aims to select the next batch of 13 start-ups of which:

The call is open to all researchers, independent teams and start-ups that wish to turn their projects into an entrepreneurial reality. Selected teams will have access to G-Force 2021, the customised Acceleration Programme offering investment, mentoring and business networking.

Life Science

The Life Science & Digital Health Call aims to support five projects through a total investment of €650,000 provided by G-Factor (through resources made available by Fondazione Golinelli) with particular attention to solutions in which the convergence between scientific disciplines and digital technology may generate potentially disruptive innovations on the current scene. In particular:

  1. Bioinformatics and bioengineering sector
  2. Medtech sector – medical and diagnostic devices
  3. Biotech Sector

powered by

Fintech & Insurtech

The FinTech & InsurTech Call aims to support five projects through a total investment of €600,000 provided by CRIF in which the convergence between any aspect of insurance, banking services and processes and digital technology may generate potentially disruptive innovations on the current scene. In particular:

  1. Alternative Evaluation of Risk
  2. New and Improved Customer Experience in the Post-Covid World
  3. Robo Advisor
  4. IoT for Insurance (Motor, Home, Health, Engineering, Construction)
  5. IoT for Banking
  6. Innovation in Claims Management
  7. Alternative Banking Services

powered by

Agritech

The AgriTech & FoodTech Call aims to support three projects through a total investment of €360,000 provided by CRIF in which the convergence between any aspect of the typical supply chain processes of the agricultural/agro-food sector and digital technologies may reasonably lead to a potentially disruptive innovation on the current scene. In particular:

  1. Farm Management Software
  2. Satellites, Drones and other Devices (IoT)
  3. Marketplace: Platforms for purchase/sale of pesticides, seeds, fertilisers, fruit and vegetables, wine, etc.
  4. Market Intelligence
  5. Traceability

powered by

Calendario

Vuoi conoscerci e avere maggiori informazioni su una delle tre call e sul programma G-Force? Registrati ad uno degli open day

Registrati

G-FORCE

An innovative Acceleration Programme tailored to entrepreneurs in the Life Sciences, Fintech & Insuretech and Agritech sectors. The programme aims to accelerate the most talented teams with a high degree of innovation and a relevant technical-scientific profile, with special focus on the business dimension.

G-Force has a total duration of eight months.

For the first three months, the acceleration foresees intensive training and daily mentoring activities, with a mixed formula between remote and residential modes; for the following five months, follow-up activities with remote mentoring one day a week are foreseen.

The 2021 acceleration itinerary is tailor-made for the three specialisation areas of the start-ups that will be selected. The programme includes face-to-face webinars, workshops, mentoring and coaching tailored to each business project, concerning all strategic issues for business development. In the second part of the programme, ad-hoc networking events are foreseen to allow new start-ups and potential industrial partners and investors to meet and create connections.

WELCOME KIT

  • Access to a network of highly qualified mentors and partners
  • Access to a network of investors
  • Legal and patent support
  • Regulatory advice
  • Media Coverage & Communications
  • Accomodation for residential phase (when covid-19 emergency will be end)

Network

We collaborate with dozens of entrepreneurs, teachers and managers with different specializations and professional backgrounds to cover all the needs of accelerated startups: from product development to business storytelling, from IP to negotiation, from hard skills to soft skills.

Our industrial partners are important international players in the world of life sciences operating in different business areas: from pharmaceutical to medical devices, from biotech to data science. Together with our industrial partners we help startups to create sustainable and scalable businesses.

Our network is enriched by the presence of research centers, startups, companies and universities that make innovation their daily mission.

We work together with some of the main Italian institutions to accompany our startups on their growth path.

Portfolio

124 applications have been received for the first call of G-Factor, Life Sciences Innovation : 30 of these have reached the final stage and 10 have been selected to participate in the acceleration process which has end in December 2019 with the awaited Investor Day. Each Startup has received an investment of €100,000 €

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

Sito web
medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

Sito web
bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

Sito web
medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

Sito web
bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

Sito web
medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

Sito web
medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

Sito web
medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

137 applications have been received for the second call of G-Factor, Life Sciences Innovation 2020: 24 of these have reached the final stage and 5 have been selected to participate in the acceleration process which will end in December 2020 with the awaited Investor Day. Each Startup will receive an investment of €125,000 of which € 90,000 of liquidity and € 35,000 in kinds.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

Sito web
medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

medtech

BCI deals with the biocompatibility of cardiac valve substitutes manufactured with animal tissues, improving their performance and doubling their durability.

Sito web
medtech

Adam's Hand is a myoelectric hand prosthesis. A single motor allows you to move all your fingers, automatically adapting them to the shape and size of the objects being handled

Sito web
bioengineering

Complexdata has developed a platform that uses artificial intelligence to estimate the risk of metastasis in cancer patients.

Sito web
medtech

Diamante specializes in the production of nanoparticles for the diagnosis of autoimmune diseases through the exploitation of plants as compounds with high added value.

Sito web
bioengineering

eVAI is cloud platform developed by enGenome to support geneticists in the diagnosis of hereditary diseases from NGS data.

Sito web
medtech

Genoa Instruments, will produce high-tech scientific instruments in the field of super-resolution optical microscopy.

Sito web
medtech

Holey has created a solution capable of producing custom-made 3D printable orthopedic braces, which can replace both traditional plaster and commercial braces.

Sito web
medtech

MgShell developed a solution to treat maculopathy capable of timing the drug release, therefore reducing the therapeutic load from several injections to a single injection.

medtech

P4P produces innovative polymeric biomaterials processed with additive manufacturing techniques to obtain advanced systems for the personalized administration of drugs.

medtech

RELIEF has created a minimally invasive endourethral device that can be inserted into the urethra of patients with severe incontinence and can be activated with a small magnet.

nutraceutica

Thanks to a patented biotechnology, Bacfarm produces deinoxanthin, the most powerful antioxidant among carotenoids and UV shield.

medtech

Innovative and unique CTC single cell blood analysis, disposable microfluidic analysis device, single cell analysis, image sorting and archiving.

Sito web
medtech

An innovative biosensor for prostate cancer to reduce the number of unnecessary tests, costs, waiting times and inconvenience for the patient.

pharma

Micro-ReSkin is a PerFormS product developed to meet the needs of patients with acute, or chronic skin inflammations such as psoriasis.

medtech

RECORNEA has developed a revolutionary solution. With a single device and in a single step it managed to improve her eyesight and stop the progression of the keratoconus.

Team

Ing. Antonio Danieli

Director General and Board Member
@ Fondazione Golinelli
CEO @ G-Factor Incubator-Accelerator

Dott.ssa Cristiana Vignoli

Director @ G-Factor Incubator-Accelerator

c.vignoli@fondazionegolinelli.it
Ing. Pietro Ferraris

Head of G-Factor Acceleration Program

p.ferraris@fondazionegolinelli.it
Dott.ssa Silvia Cozzi

Project Manager, G-Factor

s.cozzi@fondazionegolinelli.it
Elena Galli

Tutor and Startup Facilitator

e.galli@fondazionegolinelli.it
Fabio Bersani

Junior Project Manager

f.bersani@fondazionegolinelli.it

Subscribe to our newsletter

Be the first to get news and updates on our programs and events

Contact Us

How can we help you?